260 related articles for article (PubMed ID: 18519084)
21. Role of sodium depletion in acute antidiuretic effect of bendroflumethiazide in rats with nephrogenic diabetes insipidus.
Janjua NR; Jonassen TE; Langhoff S; Thomsen K; Christensen S
J Pharmacol Exp Ther; 2001 Oct; 299(1):307-13. PubMed ID: 11561093
[TBL] [Abstract][Full Text] [Related]
22. Lithium-induced nephropathies.
Raedler TJ; Wiedemann K
Psychopharmacol Bull; 2007; 40(2):134-49. PubMed ID: 17514192
[TBL] [Abstract][Full Text] [Related]
23. Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus.
Kortenoeven ML; Li Y; Shaw S; Gaeggeler HP; Rossier BC; Wetzels JF; Deen PM
Kidney Int; 2009 Jul; 76(1):44-53. PubMed ID: 19367330
[TBL] [Abstract][Full Text] [Related]
24. [Nephrogenic diabetes insipidus during lithium acute intoxication].
Abodo J; Seux V; Koffi-Dago P; Dalco O; Renaud-Lévy O; Tassy S; Million M; Lokrou A; Soubeyrand J; Retornaz F
Ann Endocrinol (Paris); 2007 Dec; 68(6):467-9. PubMed ID: 18031708
[TBL] [Abstract][Full Text] [Related]
25. [Contribution of Japanese researchers to progress in studies on nephrology in the past 100 years: Molecular cloning of water channels in the kidney collecting duct and the etiology of nephrogenic diabetes insipidus].
Sasaki S
Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1437-9. PubMed ID: 12082731
[No Abstract] [Full Text] [Related]
26. QT interval prolongation and bradycardia in lithium-induced nephrogenic diabetes insipidus.
La Rocca R; Foschi A; Preston NM; Ceriani C; Materia V; Patanè S
Int J Cardiol; 2012 Dec; 162(1):e1-2. PubMed ID: 22592036
[No Abstract] [Full Text] [Related]
27. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
[TBL] [Abstract][Full Text] [Related]
28. Secondary oxalosis induced by xylitol concurrent with lithium-induced nephrogenic diabetes insipidus: a case report.
Takayasu S; Kamba A; Yoshida K; Terui K; Watanuki Y; Ishigame N; Mizushiri S; Tomita T; Nakamura K; Yasui-Furukori N; Daimon M
BMC Nephrol; 2020 May; 21(1):157. PubMed ID: 32357847
[TBL] [Abstract][Full Text] [Related]
29. Renal effects of long-term lithium therapy in the elderly: a cross-sectional study.
van Melick EJ; Meinders AE; Hoffman TO; Egberts TC
Int J Geriatr Psychiatry; 2008 Jul; 23(7):685-92. PubMed ID: 18186456
[TBL] [Abstract][Full Text] [Related]
30. Chloroquine attenuates lithium-induced NDI and proliferation of renal collecting duct cells.
Du Y; Qian Y; Tang X; Guo Y; Chen S; Jiang M; Yang B; Cao W; Huang S; Zhang A; Jia Z; Zhang Y
Am J Physiol Renal Physiol; 2020 May; 318(5):F1199-F1209. PubMed ID: 32249612
[TBL] [Abstract][Full Text] [Related]
31. alphaENaC-mediated lithium absorption promotes nephrogenic diabetes insipidus.
Christensen BM; Zuber AM; Loffing J; Stehle JC; Deen PM; Rossier BC; Hummler E
J Am Soc Nephrol; 2011 Feb; 22(2):253-61. PubMed ID: 21051735
[TBL] [Abstract][Full Text] [Related]
32. Nephrogenic diabetes insipidus secondary to lithium therapy in the postoperative patient: a case report.
Johnson MA; Ogorman J; Golembiewski GH; Paluzzi MW
Am Surg; 1994 Nov; 60(11):836-9. PubMed ID: 7978676
[TBL] [Abstract][Full Text] [Related]
33. Triamterene in lithium-induced nephrogenic diabetes insipidus: a case report.
Inoue M; Nakai K; Mitsuiki K
CEN Case Rep; 2021 Feb; 10(1):64-68. PubMed ID: 32772236
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms in lithium-associated renal disease: a systematic review.
Rej S; Pira S; Marshe V; Do A; Elie D; Looper KJ; Herrmann N; Müller DJ
Int Urol Nephrol; 2016 Nov; 48(11):1843-1853. PubMed ID: 27357223
[TBL] [Abstract][Full Text] [Related]
35. Lithium-induced nephrogenic diabetes insipidus after gastric banding.
Leo JR; Farrell HM; Friedman R
Psychosomatics; 2013; 54(2):200-4. PubMed ID: 22658328
[No Abstract] [Full Text] [Related]
36. Lithium-induced nephrogenic diabetes insipidus.
Imam SK; Hasan A; Shahid SK
J Pak Med Assoc; 2005 Mar; 55(3):125-7. PubMed ID: 15852752
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
Fotso Soh J; Torres-Platas SG; Beaulieu S; Mantere O; Platt R; Mucsi I; Saury S; Renaud S; Levinson A; Andreazza AC; Mulsant BH; Müller D; Schaffer A; Dols A; Cervantes P; Low NC; Herrmann N; Christensen BM; Trepiccione F; Rajji T; Rej S
BMC Psychiatry; 2018 Jul; 18(1):227. PubMed ID: 30012135
[TBL] [Abstract][Full Text] [Related]
38. Acquired nephrogenic diabetes insipidus.
Khanna A
Semin Nephrol; 2006 May; 26(3):244-8. PubMed ID: 16713497
[TBL] [Abstract][Full Text] [Related]
39. Will lithium damage my kidneys?
Raedler TJ
J Psychiatry Neurosci; 2012 May; 37(3):E5-6. PubMed ID: 22515988
[No Abstract] [Full Text] [Related]
40. Lithium in the Kidney: Friend and Foe?
Alsady M; Baumgarten R; Deen PM; de Groot T
J Am Soc Nephrol; 2016 Jun; 27(6):1587-95. PubMed ID: 26577775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
